Top Markets
Coin of the day
Cardax, Inc. Cardax, Inc.

Cardax, Inc.

CDXI
Rankning i aktier #42795
Cardax, Inc. is a biopharmaceutical enterprise focused on both creating and... Cardax, Inc. is a biopharmaceutical enterprise focused on both creating and marketing nutritional supplements for maintaining inflammatory well-being, as well as developing pharmaceutical treatments for chronic ailments rooted in inflammation and oxidative stress. Its product portfolio includes ZanthoSyn, an advanced supplement for inflammation, health, and longevity that delivers astaxanthin with superior absorption and purity. This product is primarily distributed through online sales and wholesale channels. The company is also progressing two pharmaceutical candidates: CDX-101, an astaxanthin-derived drug candidate intended to address cardiovascular inflammation and dyslipidemia, with a primary focus on severe hypertriglyceridemia; and CDX-301, a zeaxanthin-based pharmaceutical currently under development for macular degeneration. Cardax, Inc. maintains its headquarters in Honolulu, Hawaii.
Aktiekurs
$0.0001
Senast synkroniserad: 2026-08-11
Marknadsvärde
$80.00
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel Cardax, Inc. (CDXI)

Kategori

Historik för aktiesplit för Cardax, Inc. (CDXI)
Aktien Cardax, Inc. (symbol: CDXI) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 13, 2026.
En CDXI-aktie köpt före Aug 13, 2026 motsvarar nu 0 CDXI-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR